Hinge Health, Inc. (HNGE)
92.37
+1.61
(+1.77%)
USD |
NYSE |
Sep 04, 16:00
92.24
-0.13
(-0.14%)
After-Hours: 20:00
Hinge Health Research and Development Expense (Quarterly) : 34.06M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.06M |
| March 31, 2026 | 30.34M |
| December 31, 2025 | 32.76M |
| September 30, 2025 | 31.92M |
| June 30, 2025 | 279.96M |
| March 31, 2025 | 23.50M |
| December 31, 2024 | 22.37M |
| Date | Value |
|---|---|
| September 30, 2024 | 23.78M |
| June 30, 2024 | 24.92M |
| March 31, 2024 | 29.76M |
| December 31, 2023 | 28.58M |
| September 30, 2023 | 28.46M |
| June 30, 2023 | 27.80M |
| March 31, 2023 | 25.22M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median